Biomarker Testing in Non-Small Cell Lung Cancer A Clinician's Perspective

被引：5
作者：
Bernicker, Eric [1 ]
机构：
[1] Houston Methodist Hosp, Thorac Med Oncol, Houston, TX 77030 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2015年 / 139卷 / 04期
关键词：
PHASE-II TRIAL; 1ST-LINE TREATMENT; OPEN-LABEL; EGFR; CHEMOTHERAPY; MUTATIONS; ERLOTINIB; CARBOPLATIN; COMBINATION; PACLITAXEL;
D O I：
10.5858/arpa.2014-0085-ED
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：448 / 450
页数：3
相关论文
共 26 条
  • [1] [Anonymous], J CLIN ONCOL S
  • [2] [Anonymous], 2013, ASCO M
  • [3] Early clinical results of intraoperative radiation therapy (IORT) during breast conservation using an electronic brachytherapy (EBX) technique.
    Arterbery, V. Elayne
    Johnson, Pamela
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [4] The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
    Atherly, A. J.
    Camidge, D. R.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (06) : 1100 - 1106
  • [5] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
    Brahmer, Julie R.
    Tykodi, Scott S.
    Chow, Laura Q. M.
    Hwu, Wen-Jen
    Topalian, Suzanne L.
    Hwu, Patrick
    Drake, Charles G.
    Camacho, Luis H.
    Kauh, John
    Odunsi, Kunle
    Pitot, Henry C.
    Hamid, Omid
    Bhatia, Shailender
    Martins, Renato
    Eaton, Keith
    Chen, Shuming
    Salay, Theresa M.
    Alaparthy, Suresh
    Grosso, Joseph F.
    Korman, Alan J.
    Parker, Susan M.
    Agrawal, Shruti
    Goldberg, Stacie M.
    Pardoll, Drew M.
    Gupta, Ashok
    Wigginton, Jon M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) : 2455 - 2465
  • [6] Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer
    Church, Timothy R.
    Black, William C.
    Aberle, Denise R.
    Berg, Christine D.
    Clingan, Kathy L.
    Duan, Fenghai
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gierada, David S.
    Jones, Gordon C.
    Mahon, Irene
    Marcus, Pamela M.
    Sicks, JoRean D.
    Jain, Amanda
    Baum, Sarah
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (21) : 1980 - 1991
  • [7] Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non-Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications
    Gandara, David R.
    Li, Tianhong
    Lara, Primo N.
    Kelly, Karen
    Riess, Jonathan W.
    Redman, Mary W.
    Mack, Philip C.
    [J]. CLINICAL LUNG CANCER, 2014, 15 (01) : 1 - 6
  • [8] Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
    Goldberg, Sarah B.
    Oxnard, Geoffrey R.
    Digumarthy, Subba
    Muzikansky, Alona
    Jackman, David M.
    Lennes, Inga T.
    Sequist, Lecia V.
    [J]. ONCOLOGIST, 2013, 18 (11) : 1214 - 1220
  • [9] Activity and tolerability of afatinib (BIBW 2992) and cetuximab in NSCLC patients with acquired resistance to erlotinib or gefitinib
    Janjigian, Y. Y.
    Groen, H. J.
    Horn, L.
    Smit, E. F.
    Fu, Y.
    Wang, F.
    Shahidi, M.
    Denis, L. J.
    Pao, W.
    Miller, V. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
    Johnson, DH
    Fehrenbacher, L
    Novotny, WF
    Herbst, RS
    Nemunaitis, JJ
    Jablons, DM
    Langer, CJ
    DeVore, RF
    Gaudreault, J
    Damico, LA
    Holmgren, E
    Kabbinavar, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2184 - 2191
123